Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer
JAMA Network Open | June 24, 2026 | Volume: 9 | Issue: 6 | Pages: e2620084
10.1001/jamanetworkopen.2026.20084
| PMID 42340725
This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.